For Whom is Hepatocellular Carcinoma Surveillance After Sustained Virologic Response Cost-Effective?

被引：5
作者：
Singal, Amit G. [1 ]
Ioannou, George N. [2 ,3 ,4 ]
机构：
[1] UT Southwestern Med Ctr, Div Digest & Liver Dis, Dallas, TX 75390 USA
[2] Vet Affairs Puget Sound Healthcare Syst, Dept Med, Div Gastroenterol, Seattle, WA USA
[3] Univ Washington, Seattle, WA 98195 USA
[4] Vet Affairs Puget Sound Healthcare Syst, Res & Dev, Seattle, WA USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2019年 / 17卷 / 09期
关键词：
TRANSIENT ELASTOGRAPHY; LIVER-BIOPSY; RISK; CIRRHOSIS; FIBROSIS;
D O I：
10.1016/j.cgh.2019.02.020
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1732 / 1735
页数：4
相关论文
共 20 条
[1]  
American Association for the Study of Liver Diseases (AASLD) Infectious Diseases Society of America (IDSA), 2018, HCV GUID REC TEST MA
[2]   Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C [J].
Castéra, L ;
Vergniol, J ;
Foucher, J ;
Le Bail, B ;
Chanteloup, E ;
Haaser, M ;
Darriet, M ;
Couzigou, P ;
De Lédinghen, V .
GASTROENTEROLOGY, 2005, 128 (02) :343-350
[3]   Use of Surveillance for Hepatocellular Carcinoma Among Patients With Cirrhosis in the United States [J].
Davila, Jessica A. ;
Morgan, Robert O. ;
Richardson, Peter A. ;
Du, Xianglin L. ;
McGlynn, Katherine A. ;
El-Serag, Hashem B. .
HEPATOLOGY, 2010, 52 (01) :132-141
[4]  
European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019
[5]   Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis [J].
Goossens, Nicolas ;
Singal, Amit G. ;
King, Lindsay Y. ;
Andersson, Karin L. ;
Fuchs, Bryan C. ;
Besa, Cecilia ;
Taouli, Bachir ;
Chung, Raymond T. ;
Hoshida, Yujin .
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2017, 8
[6]   Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma [J].
Hoshida, Yujin ;
Villanueva, Augusto ;
Kobayashi, Masahiro ;
Peix, Judit ;
Chiang, Derek Y. ;
Camargo, Amy ;
Gupta, Supriya ;
Moore, Jamie ;
Wrobel, Matthew J. ;
Lerner, Jim ;
Reich, Michael ;
Chan, Jennifer A. ;
Glickman, Jonathan N. ;
Ikeda, Kenji ;
Hashimoto, Masaji ;
Watanabe, Goro ;
Daidone, Maria G. ;
Roayaie, Sasan ;
Schwartz, Myron ;
Thung, Swan ;
Salvesen, Helga B. ;
Gabriel, Stacey ;
Mazzaferro, Vincenzo ;
Bruix, Jordi ;
Friedman, Scott L. ;
Kumada, Hiromitsu ;
Llovet, Josep M. ;
Golub, Todd R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (19) :1995-2004
[7]   Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C [J].
Ioannou, George N. ;
Green, Pamela K. ;
Beste, Lauren A. ;
Mun, Elijah J. ;
Kerr, Kathleen F. ;
Berry, Kristin .
JOURNAL OF HEPATOLOGY, 2018, 69 (05) :1088-1098
[8]   HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma [J].
Ioannou, George N. ;
Green, Pamela K. ;
Berry, Kristin .
JOURNAL OF HEPATOLOGY, 2018, 68 (01) :25-32
[9]   Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease [J].
Kanwal, Fasiha ;
Kramer, Jennifer R. ;
Mapakshi, Srikar ;
Natarajan, Yamini ;
Chayanupatkul, Maneerat ;
Richardson, Peter A. ;
Li, Liang ;
Desiderio, Roxanne ;
Thrift, Aaron P. ;
Asch, Steven M. ;
Chu, Jinna ;
El-Serag, Hashem B. .
GASTROENTEROLOGY, 2018, 155 (06) :1828-+
[10]   Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents [J].
Kanwal, Fasiha ;
Kramer, Jennifer ;
Asch, Steven M. ;
Chayanupatkul, Maneerat ;
Cao, Yumei ;
El-Serag, Hashem B. .
GASTROENTEROLOGY, 2017, 153 (04) :996-+
12